EUVIMEDEUVIMED entdecken
Fallbericht

Early anticoagulant resumption after atypical intracerebral hemorrhage: beyond atrial fibrillation analysis of two clinical cases admitted to the University Hospital of Pisa

Gaia Mignani, Marta Del Chicca, Roberto D'Agliano, Marco Baldini, Margherita Giannini, Nicola Giannini

Neurological Sciences · 2025

DOI: 10.1007/s10072-025-08322-4 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neurological Sciences, 2025. Verfasst von Gaia Mignani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy. g.mignani2@studenti.unipi.it. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Cerebral Hemorrhage. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The literature extensively addresses the timing of anticoagulant therapy resumption after lobar intracerebral hemorrhage (ICH) in patients with atrial fibrillation (AF). However, there is few data for patients with lobar (atypical) ICH requiring anticoagulation for non-AF indications. CASES DESCRIPTION: We present two cases of non-surgical, medium-sized lobar ICH where anticoagulant therapy was resumed early: the first case involved a hypertensive patient on warfarin and clopidogrel for left ventricular thrombosis following acute myocardial infarction and coronary stenting; the second one a patient with probable cerebral amyloid angiopathy (CAA) on warfarin (INR 3.87 at onset) due to an aortic valve prosthesis. Alternative treatments to anticoagulation were not viable in either case, necessitating early resumption of therapy. During follow-up, no clinical or radiological evidence of rebleeding was observed in either patient. CONCLUSIONS: These cases suggest that early anticoagulation resumption (within 4 weeks) may be safe in the short term, even in patients with a high risk of rebleeding and no alternative options. Evidence-based guidelines are urgently needed, particularly for patients with non-AF conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAtrial FibrillationCerebral HemorrhageHumansCerebral Amyloid AngiopathyHospitals, UniversityWarfarin

Stichwörter der Autor:innen

AnticoagulationCerebral amyloid angiopathyLeft ventricular thrombosisLobar intracerebral hemorrhageMechanical heart valves

Substanzen

AnticoagulantsWarfarin

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy. g.mignani2@studenti.unipi.it.
  • Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.

Zitieren

APA

Mignani, G., Del Chicca, M., D'Agliano, R., Baldini, M., Giannini, M., & Giannini, N. (2025). Early anticoagulant resumption after atypical intracerebral hemorrhage: beyond atrial fibrillation analysis of two clinical cases admitted to the University Hospital of Pisa. Neurological Sciences. https://doi.org/10.1007/s10072-025-08322-4

Vancouver

Mignani G, Del Chicca M, D'Agliano R, Baldini M, Giannini M, Giannini N. Early anticoagulant resumption after atypical intracerebral hemorrhage: beyond atrial fibrillation analysis of two clinical cases admitted to the University Hospital of Pisa. Neurological Sciences. 2025. doi:10.1007/s10072-025-08322-4

BibTeX
@article{Mignani2025,
  author = {Mignani, Gaia and Del Chicca, Marta and D'Agliano, Roberto and Baldini, Marco and Giannini, Margherita and Giannini, Nicola},
  title = {Early anticoagulant resumption after atypical intracerebral hemorrhage: beyond atrial fibrillation analysis of two clinical cases admitted to the University Hospital of Pisa},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-025-08322-4}
}
Kostenlos starten →